BMC Psychiatry

official impact factor 2.89

Open Access Email this article to a friend

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Paul D Carey*, Bavanisha Vythilingum, Soraya Seedat, Jacqueline E Muller, Michael van Ameringen and Dan J Stein

BMC Psychiatry 2005, 5:5 doi:10.1186/1471-244X-5-5

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.